Goodwill and Intangible Assets (Details) - USD ($) $ in Millions |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Apr. 03, 2026 |
Mar. 28, 2025 |
Apr. 03, 2026 |
Mar. 28, 2025 |
|
| Intangible Asset, Goodwill and Other [Abstract] | ||||
| Goodwill, period increase (decrease) | $ 0.0 | $ 0.0 | ||
| Goodwill, impairment loss | 0.0 | 0.0 | ||
| Intangible Asset, Finite-Lived [Line Items] | ||||
| Asset impairment charges | 0.0 | $ 0.0 | 0.0 | $ 0.0 |
| Completed and transferred in-process research and development | 0.0 | $ 24.7 | 0.0 | $ 24.7 |
| Finite-lived intangible assets, useful life | 8 years | 8 years | ||
| Amortization of intangible assets | 42.9 | $ 45.6 | 87.5 | $ 94.0 |
| In-process research and development | ||||
| Intangible Asset, Finite-Lived [Line Items] | ||||
| Asset impairment charges | $ 0.0 | $ 0.0 | $ 0.0 | $ 0.0 |
| X | ||||||||||
- Definition Completed and transferred in-process research and development No definition available.
|
| X | ||||||||||
- Definition Amount of amortization expense for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss for asset. Includes, but is not limited to, tangible and intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible asset, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of increase (decrease) of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|